Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 10.37% is 39% below its 5-year average of 16.97%, near the low end of its 5-year range (10.37%–31.75%).
9.04% below its 12-month average of 11.40%.
Annual fiscal-year return on assets; no daily interpolation. Historical series through 2025-12-31.
RETURN ON ASSETS (ROA)
10.37%
RETURN ON ASSETS (ROA) AVG TTM
11.40%
RETURN ON ASSETS (ROA) AVG 3Y
12.40%
RETURN ON ASSETS (ROA) AVG 5Y
16.97%
RETURN ON ASSETS (ROA) AVG 10Y
15.89%
RETURN ON ASSETS (ROA) AVG 15Y
13.87%
RETURN ON ASSETS (ROA) AVG 20Y
6.43%
CURRENT VS TTM AVG
-9.04%
CURRENT VS 3Y AVG
-16.37%
CURRENT VS 5Y AVG
-38.89%
CURRENT VS 10Y AVG
-34.74%
CURRENT VS 15Y AVG
-25.22%
CURRENT VS 20Y AVG
+61.22%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+101.75%
vs the sector median at left
Regeneron Pharmaceuticals, Inc.
Market Cap
$83.21B
Return on Assets (ROA)
10.37%
TTM Avg
11.40%
3Y Avg
12.40%
5Y Avg
16.97%
Market Cap
$86.08B
Return on Assets (ROA)
3.93%
TTM Avg
4.89%
3Y Avg
5.25%
5Y Avg
5.41%
Market Cap
$91.33B
Return on Assets (ROA)
11.30%
TTM Avg
10.43%
3Y Avg
10.23%
5Y Avg
10.42%
Market Cap
$73.50B
Return on Assets (ROA)
4.08%
TTM Avg
2.99%
3Y Avg
3.50%
5Y Avg
3.82%
Market Cap
$66.83B
Return on Assets (ROA)
8.11%
TTM Avg
5.66%
3Y Avg
4.50%
5Y Avg
3.49%
Market Cap
$62.91B
Return on Assets (ROA)
3.13%
TTM Avg
2.14%
3Y Avg
2.52%
5Y Avg
0.85%
Market Cap
$104.40B
Return on Assets (ROA)
5.20%
TTM Avg
5.08%
3Y Avg
5.08%
5Y Avg
2.52%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. (REGN) | $83.21B | 10.37% | 11.40% | 12.40% | 16.97% |
| Elevance Health Inc. (ELV)vs › | $86.08B | 3.93% | 4.89% | 5.25% | 5.41% |
| HCA Healthcare, Inc. (HCA)vs › | $91.33B | 11.30% | 10.43% | 10.23% | 10.42% |
| Cigna Corporation (CI)vs › | $73.50B | 4.08% | 2.99% | 3.50% | 3.82% |
| GSK plc (GSK)vs › | $97.43B | 7.91% | 6.85% | 11.28% | 9.07% |
| Boston Scientific Corporation (BSX)vs › | $66.83B | 8.11% | 5.66% | 4.50% | 3.49% |
| Sanofi (SNY)vs › | $102.89B | 3.12% | 5.18% | 5.31% | 6.19% |
| Cencora, Inc. (COR)vs › | $62.91B | 3.13% | 2.14% | 2.52% | 0.85% |
| McKesson Corporation (MCK)vs › | $104.40B | 5.20% | 5.08% | 5.08% | 2.52% |
| Stryker Corporation (SYK)vs › | $105.57B | 7.78% | 6.88% | 7.02% | 6.41% |
ROA
10.4%
ROE
13.7%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 11.11% |
| 2024-12-31 | 11.69% |
| 2023-12-31 | 11.95% |
| 2022-12-31 | 14.85% |
| 2021-12-31 | 31.75% |
| 2020-12-31 | 20.47% |
| 2019-12-31 | 14.29% |
| 2018-12-31 | 20.83% |
| 2017-12-31 | 13.67% |
| 2016-12-31 | 12.84% |
| 2015-12-31 | 11.34% |
| 2014-12-31 | 8.99% |
| 2013-12-31 | 14.38% |
| 2012-12-31 | 36.06% |
| 2011-12-31 | -16.75% |
| 2010-12-31 | -9.59% |
| 2009-12-31 | -9.15% |
| 2008-12-31 | -12.34% |
| 2007-12-31 | -11.28% |
| 2006-12-31 | -17.49% |
| 2005-12-31 | -22.54% |
| 2004-12-31 | 8.81% |
| 2003-12-31 | -22.41% |
| 2002-12-31 | -31.76% |
| 2001-12-31 | -15.38% |
| 2000-12-31 | -11.15% |
| 1999-12-31 | -16.86% |
| 1998-12-31 | -5.48% |
| 1997-12-31 | -6.89% |
| 1996-12-31 | -23.55% |
